Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    22545106 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed OmegAD (Omega-3 and Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: EPAX 1050TG

Study has passed its completion date and status has not been verified in more than two years.